|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Equity-based compensation | |||||
| Depreciation and amortization | |||||
| Restructuring Charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense) income, net | |||||
| Other income (expense), net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss and comprehensive loss | |||||
| Loss attributable to noncontrolling interest | |||||
| Net loss attributable to Zevia PBC | |||||
| Net loss per share attributable to common stockholders | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...